Clinical Trials: Psychotropic Drugs
- Alprazolam 49 studies
- Amitriptyline 59 studies
- Amitriptyline, perphenazine drug combination 59 studies
- Anti-Anxiety Agents 726 studies
- Antidepressive Agents 1816 studies
- Antidepressive Agents, Second-Generation 912 studies
- Antidepressive Agents, Tricyclic 190 studies
- Antimanic Agents 557 studies
- Antipsychotic Agents 1754 studies
- Aripiprazole 249 studies
- Asenapine 36 studies
- Azaperone 1 study
- Bupropion 210 studies
- Buspirone 22 studies
- Carbamazepine 94 studies
- Chlordiazepoxide 3 studies
- Chlorpromazine 8 studies
- Chlorprothixene 1 study
- Citalopram 368 studies
- Clomipramine 15 studies
- Clopenthixol 1 study
- Clorazepate Dipotassium 2 studies
- Clozapine 82 studies
- Cyclobenzaprine 16 studies
- Desipramine 33 studies
- Diazepam 43 studies
- Doxepin 6 studies
- Droperidol 9 studies
- Duloxetine 196 studies
- Estazolam 2 studies
- Etazolate 1 study
- Fluoxetine 151 studies
- Flupenthixol 6 studies
- Flupenthixol decanoate 6 studies
- Fluphenazine 8 studies
- Fluphenazine depot 8 studies
- Fluphenazine enanthate 8 studies
- Fluspirilene 3 studies
- Fluvoxamine 19 studies
- Gabapentin 173 studies
- Gepirone 1 study
- Hallucinogens 85 studies
- Haloperidol 91 studies
- Haloperidol decanoate 91 studies
- Honokiol 1 study
- Hypericin 2 studies
- Imipramine 21 studies
- Lithium 153 studies
- Lithium Carbonate 153 studies
- Lorazepam 77 studies
- Loxapine 18 studies
- Lysergic Acid Diethylamide 1 study
- Methotrimeprazine 2 studies
- Metylperon 2 studies
- Mianserin 29 studies
- Midazolam 261 studies
- Milnacipran 42 studies
- Mirtazapine 52 studies
- Moclobemide 2 studies
- Molindone 3 studies
- N,N-Dimethyltryptamine 2 studies
- N-Methyl-3,4-methylenedioxyamphetamine 23 studies
- Nabilone 14 studies
- Nefazodone 5 studies
- Nefiracetam 1 study
- Nitrazepam 3 studies
- Nortriptyline 35 studies
- O-desmethylvenlafaxine 52 studies
- Olanzapine 303 studies
- Ondansetron 165 studies
- Oxazepam 2 studies
- Paroxetine 174 studies
- Perphenazine 51 studies
- Phenelzine 3 studies
- Pimozide 3 studies
- Pipamperone 3 studies
- Prochlorperazine 15 studies
- Protriptyline 2 studies
- Psilocybine 6 studies
- Quetiapine 318 studies
- Raclopride 16 studies
- Reboxetine 24 studies
- Reserpine 5 studies
- Risperidone 470 studies
- Ritanserin 1 study
- Rolipram 4 studies
- Sch 39166 4 studies
- Sertindole 13 studies
- Sertraline 203 studies
- Sibutramine 31 studies
- Sulpiride 12 studies
- Sultopride 27 studies
- Temazepam 7 studies
- Tetrahydrocannabinol 65 studies
- Thioridazine 3 studies
- Thiothixene 2 studies
- Tianeptine 2 studies
- Tiapride 4 studies
- Tofisopam 2 studies
- Tranquilizing Agents 2485 studies
- Tranylcypromine 11 studies
- Trazodone 22 studies
- Triazolam 7 studies
- Trifluoperazine 2 studies
- Tryptophan 23 studies
- Valproic Acid 248 studies
- Venlafaxine 137 studies
- Ziprasidone 114 studies
- Zotepine 4 studies
- 2,5-Dimethoxy-4-Methylamphetamine 1 study
- 3,4-Methylenedioxyamphetamine 21 studies
- 5-Hydroxytryptophan 6 studies
- 9-hydroxy-risperidone 120 studies
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://www.clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_PsychDr
